0001209191-23-038597.txt : 20230621
0001209191-23-038597.hdr.sgml : 20230620
20230620183610
ACCESSION NUMBER: 0001209191-23-038597
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230616
FILED AS OF DATE: 20230620
DATE AS OF CHANGE: 20230620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allison David D.
CENTRAL INDEX KEY: 0001853903
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40353
FILM NUMBER: 231026889
MAIL ADDRESS:
STREET 1: C/O 5AM VENTURES
STREET 2: 501 2ND STREET, SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPEL PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001445499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263058238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0426
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-568-1466
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
FORMER COMPANY:
FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC
DATE OF NAME CHANGE: 20080917
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-16
0
0001445499
IMPEL PHARMACEUTICALS INC
IMPL
0001853903
Allison David D.
C/O IMPEL PHARMACEUTICALS INC.
201 ELLIOTT AVE. W, STE 260
SEATTLE
WA
98119
1
0
0
0
0
Stock Option (right to buy)
1.34
2023-06-16
4
A
0
13222
0.00
A
2033-06-15
Common Stock
13222
13222
D
The option is 100% vested on June 16, 2024.
/s/ John Hoekman, Ph.D. as attorney-in-fact
2023-06-20